Searchable abstracts of presentations at key conferences in endocrinology

ea0065p351 | Reproductive Endocrinology and Biology | SFEBES2019

Igf2 regulates placental endocrine capacity in the mouse placenta

Aykroyd Bethany , Tunster Simon , Sferruzzi-Perri Amanda

Introduction: Abnormal fetal growth can cause perinatal morbidity and mortality. The placenta regulates materno-fetal nutrient transfer and secretes hormones with maternal physiological effects. In mice, global loss of insulin-like growth factor 2 (Igf2), a paternally-expressed imprinted gene, causes fetoplacental growth restriction in association with changes in placental transport and endocrine zone (Jz) formation. However, the role of Igf2 in regulating pl...

ea0031p289 | Pituitary | SFEBES2013

Maternal corticosterone regulates amino acid allocation to fetal growth in mice

Vaughan Owen , Sferruzzi-Perri Amanda , Fowden Abigail

Synthetic glucocorticoid administration during pregnancy reduces birth weight and increases disease risk in the offspring. This study investigated whether increasing maternal natural corticosterone levels, by endogenous stress or exogenous administration, alters fetal amino acid supply in the mouse.C57BL6/J dams (n=82) were exposed to daily restraint and subcutaneous saline injection (stress) or given corticosterone (cort, 82±11 &#...

ea0011p829 | Thyroid | ECE2006

Safety of pharmacological treatment of thyroid diseases during pregnancy

Gianetti E , Tonacchera M , Russo L , Perri A , Vitti P , Pinchera A

Pregnant women may require treatment of hypo- or hyperthyroidism, L-thyroxine (LT4), propylthiouralcil (PTU) and methimazole (MMI) being the most frequently used drugs. Aim of this study was to verify the consequences on both the mother and the fetus of pharmacological treatment during pregnancy. We retrospectively evaluated 292 pregnancies: 63 patients under MMI treatment, 8 of whom (7 Graves’ (GD) and 1 toxic nodular goiter) still hyperthyroid in spite of treatment (H-M...

ea0011p830 | Thyroid | ECE2006

Increase of L-thyroxine requirement during pregnancy

Russo L , Tonacchera M , Gianetti E , Perri A , Vitti P , Pinchera A

In pregnant women with thyroid diseases an increased amount of LT4 may be required for the correction of hypothyroidism or treatment of nodular goiter. Aim of this study was to assess the amount of the variations of LT4 requirement in pregnant women with thyroid diseases. To address this issue, we retrospectively evaluated a cohort of 107 women treated with LT4 divided in two groups: 42 euthyroid (E) (affected by nodular goiter (NG) treated with LT4 suppressive therapy) and 65...

ea0065p355 | Reproductive Endocrinology and Biology | SFEBES2019

Identifying placental hormones regulating maternal physiology during pregnancy – potential diagnostic and treatment markers for pregnancy complications

Napso Tina , Zhao Xiaohui , Lopez-Tello Jorge , Hamilton Russell S. , Sferruzzi-Perri Amanda N

Pregnancy is characterised by profound changes in maternal physiology. For instance, there are changes in the metabolic, cardiovascular, immune and renal systems of the mother which enable her to support fetal nutrient supply and growth. These changes are signalled in part by the production of protein hormones by the placenta (Napso et al., 2018). Failures in maternal adaptation and placental function lead to pregnancy complications such as abnormal birth weight and g...

ea0090p468 | Reproductive and Developmental Endocrinology | ECE2023

In vitro evaluation of the impact of two differently glycosylated recombinant FSH on signal transduction

Mascolo Elisa , Baschieri Lara , Roy Neena , Lazzaretti Clara , Paradiso Elia , Perri Carmela , Sperduti Samantha , Simoni Manuela , Casarini Livio

Follicle stimulating hormone (FSH) is produced by the anterior pituitary gland and it is a key hormone in the reproductive system. FSH is a heterodimeric glycoprotein composed with two extensively glycosylated protein sobunits (α and β) N-glycosylated in two positions (Asn52 and Asn78 in the FSHα subunit and Asn7 and Asn24 in the FSHβ subunit) giving rise to numerous isoforms of FSH. Glycosylation has been shown t...

ea0070aep782 | Reproductive and Developmental Endocrinology | ECE2020

New data in turner syndrome: Results from a long-term prospective observational study from diagnosis to adulthood

Corzani Francesca , Cecchetti Carolina , Oriolo Claudia , Altieri Paola , Perri Annamaria , Scarano Emanuela , Mazzanti Laura , Pagotto Uberto , Gambineri Alessandra

Turner syndrome (TS), one of the most frequent chromosomal aberrations in females, is characterized not only by structural abnormalities (somatic and congenital) but also by acquired comorbidities, such as metabolic disorders, cardiovascular alterations, autoimmune diseases, osteoporosis, and malignancies. The prevalence of structural abnormalities that usually complicate TS at diagnosis is well known. However, the prevalence of acquired complications, that may appear at any a...

ea0011p823 | Thyroid | ECE2006

Etiology of congenital hypothyroidism in children with a normal located thyroid gland

Di Cosmo C , Tonacchera M , De Marco G , Agretti P , Banco ME , Perri A , Ramos H , Ceccarelli C , Vitti P , Pinchera A

Congenital hypothyroidism (CH) with a normal located thyroid gland may be transient or permanent and environmental, iatrogenic, immunologic or genetic factors can be involved. PAX-8, TSH receptor and THOX2 gene mutations have been identified in cases of CH with a gland of normal size.In this study we performed genetic analysis of PAX8, TSH receptor and THOX2 genes in 14 children with CH and a normal sized eutopic gland. Genomic DNA was extracted from lym...

ea0090oc4.5 | Oral Communications 4: Reproductive and Developmental Endocrinology | ECE2023

Reprogramming of reproductive signals via human luteinizing hormone/choriogonadotropin receptor (LHCGR)/G protein-coupled estrogen receptor (GPER) heteromers

Lazzaretti Clara , Paradiso Elia , Sperduti Samantha , Sayers Niamh , Pelagatti Ginevra , D'Alessandro Sara , Perri Carmela , Baschieri Lara , Mascolo Elisa , Roy Neena , Simoni Manuela , Hanyaloglu Aylin , Casarini Livio

In the ovary, the G protein-coupled estrogen receptor (GPER) forms heteromeric complexes with the follicle-stimulating hormone receptor (FSHR), reprogramming FSH-induced signals and determining the follicular fate. Based on the structural similarity, we evaluated whether GPER interacts with the luteinizing hormone (LH)/choriogonadotropin (hCG) receptor (LHCGR) modulating gonadotropin-dependent signals. LHCGR-GPER heteromers were evaluated in transiently transfected HEK293 cell...

ea0090rc2.5 | Rapid Communications 2: Thyroid | ECE2023

Lack of GPER-TSHR heteromers is a hallmark of thyroid cancer

Perri Carmela , D'Alessandro Sara , Paradiso Elia , Lazzaretti Clara , Mascolo Elisa , Baschieri Lara , Roy Neena , Sperduti Samantha , Simoni Manuela , Brigante Giulia , Casarini Livio

Thyroid cancer is the most common type of endocrine tumor and reaches the peak of incidence between the age of twenty and fifty years. It has 4-fold higher prevalence in females than males, suggesting that estrogens and their receptors could be involved in thyroid cancer pathogenesis. Previous studies demonstrated allosteric interference operated by G protein-coupled estrogen receptor (GPER) to molecules structurally similar to the thyroid-stimulating hormone (TSH) receptor (T...